Skip to main content
OpenTrials

Clinical trial condition

Advanced Pancreatic Cancer

Explore clinical trials studying Advanced Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

35 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Advanced Pancreatic Cancer trial results

Completed

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

NCT03336216

Conditions
Advanced Pancreatic Cancer
Locations
  • Mayo Clinic in Rochester, Minnesota Phoenix, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Local Institution - 0007 Los Angeles, California, United States
  • University Of Colorado Aurora, Colorado, United States
View all 41 locations
View Trial Details
Completed

Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer

NCT04617067

Conditions
Advanced Pancreatic Cancer
Locations
  • Tallaght University Hospital Dublin, Dublin 24, Ireland
  • St. Vincent's University Hospital Dublin, Dublin 4, Ireland
  • Beaumont Hospital Dublin, Dublin 9, Ireland
  • Cork University Hospital Cork, Ireland
View Trial Details
Completed

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

NCT03331562

Conditions
Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Atlantic Medical Group-Oncology Morristown Medical Center Morristown, New Jersey, United States
View Trial Details
Completed

Web-based Treatment Information Tool for People With Advanced Pancreatic Cancer

NCT03632850

Conditions
Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Royal Bournemouth and Christchurch Hospitals Bournemouth, United Kingdom
  • Dorset County Hospital NHS Foundation Trust Dorchester, United Kingdom
  • Poole Hospital NHS Foundation Trust Poole, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details
Completed

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

NCT01764477

Conditions
Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer

NCT02382263

Conditions
Advanced Pancreatic Cancer
Locations
  • Complexo Hospitalario Universitario A Coruña A Coruña, Spain
  • Complexo Hospitalario Universitario de Santiago Santiago de Compostela, A Cosuña, Spain
  • Hospital Universitari Vall D'Hebron Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
View all 15 locations
View Trial Details
Completed

Supportive Care Intervention-Pancreas

NCT01885884

Conditions
Advanced Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI), Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions